Ontology highlight
ABSTRACT: Background: Unlike the reported CA, the abundance of fecal GCA did not significantly increase after DSS treatment in C57BL/6J mice. Hence, exogenous supplementation of GCA were given to DSS-induced colitis mice via oral gavage. We want to know whether GCA treatment at 200 mg/kg yielded fecal GCA concentration in human IBD patients. Methods: 200 mg/kg GCA were given to 2 % DSS-induced colitis mice via oral gavage for 7 days. Fecal samples were collected from the mice after 7 days treatment post-treatment for metabolomic analysis of bile acids.
INSTRUMENT(S): Liquid Chromatography MS - negative - reverse-phase
PROVIDER: MTBLS14032 | MetaboLights | 2026-05-03
REPOSITORIES: MetaboLights
| Action | DRS | |||
|---|---|---|---|---|
| ctrl.mzML | Mzml | |||
| gca.mzML | Mzml | |||
| untreated.mzML | Mzml | |||
| a_MTBLS14032_LC-MS_negative_reverse-phase_metabolite_profiling-1.txt | Txt | |||
| i_Investigation.txt | Txt |
Items per page: 1 - 5 of 7 |